A08 — Integrated characterization-to-reassessment workflow

• Input [inference]: A knowledge artifact, its purpose and uses, evidence, observed weaknesses, and a prospective test.
• Operation [direct/inference]: Characterize the artifact; redesign it with evidence-linked structure; test the result; route observations through an evidence decision record and review before selecting the next experiment or reassessment.
• Output [direct/inference]: Characterization, redesigned artifact, test observations, evidence decision record, review outcome, and next action.
• Scope conditions [direct]: The current research program is stronger as characterization and redesign work than as framework generation; findings remain provisional.
• Failure conditions [direct/inference]: Redesign does not improve outputs, added structure reduces usefulness, or a downstream experiment starts before accepted review selects it.
• Predicted effect [absent]: No non-additive interaction or sequencing effect is specified.
• Measurement [absent]: No bundle-level interaction contrast is defined.
• Named baseline [absent]: No matched workflow baseline is frozen.
• Boundary condition [direct]: Product use does not validate research; evidence must survive review before informing design.
• Implementation test [inference]: From a frozen input, independently produce every stage artifact and verify that the accepted review, not intuition, selects the next action.
• Decision rights [direct]: Evidence decision record precedes hypothesis review; accepted review output governs downstream selection.
• Uncertainty handling [direct]: Preserve negative, mixed, and uncertain findings; confidence is not updated directly from a run.
• Verification [direct]: Review after evidence decision record; redesign claims require stronger controlled follow-on tests.
• Provenance [direct/inference]: Carry source, redesign, test, evidence-decision, and review links through the flow.
• Implementation cost [direct/inference]: Multi-stage structure adds complexity and overhead.
• Limitations [direct]: No demonstrated bundle interaction; internal evidence; possible generic-structure explanation.
• Fidelity check [inference]: No stage silently changes confidence or bypasses review.
• Null-capable future experiment [inference]: Factorial or ablation study can find no interaction, no sequencing gain, or increased overhead.

Statement basis

• Direct: Program scope, evidence-to-review flow, decision constraints, uncertainty rules, and known limitations.
• Inference: Bundle input/output, consolidated operation, test, provenance, fidelity check, and future study.
• Proposal-only: None beyond provisional theory and heuristics.
• Absent: Interaction model, bundle prediction, metric, and matched baseline.